Myeloma Novel Drug Targets and agents
Vaccinating against mutated RAS in multiple myeloma: The phase I/II TG01 study
Hanne Marie Norseth, MD (she/her/hers)
Medical doctor
Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and University of Oslo
Oslo, Oslo, Norway